Mrs. Shirley Xu
Yonghua Capital is an institutional investor, with headquarter in Shanghai and portfolio overseas. We have invested in over 40 companies in healthcare field over past 5 years.
Yonghua Capital
Executive DirectorMr. Evan Xu
Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.
Genetron Health
Chief Financial OfficerGrace Yin
SIRC is specialized in natural drug discovery from Chinese Medicine. It has a TCM data base including 270,000 prescriptions, 9,000 herbs and 50,000 herb-derived compounds. We provide the customized drug discovery based on natural herbs.